PMC:7402624 / 51244-51477 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T437","span":{"begin":156,"end":160},"obj":"Body_part"}],"attributes":[{"id":"A437","pred":"fma_id","subj":"T437","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"esponses. To investigate this immune signature, we identified 20 patients who had responses more similar to HD and RD for five activated/responding B and T cell populations (Fig. 6J, middle, and fig. S10). If the UMAP Components 1 an"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1684","span":{"begin":65,"end":73},"obj":"Species"},{"id":"1693","span":{"begin":108,"end":110},"obj":"Disease"}],"attributes":[{"id":"A1684","pred":"tao:has_database_id","subj":"1684","obj":"Tax:9606"},{"id":"A1693","pred":"tao:has_database_id","subj":"1693","obj":"MESH:D006816"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"esponses. To investigate this immune signature, we identified 20 patients who had responses more similar to HD and RD for five activated/responding B and T cell populations (Fig. 6J, middle, and fig. S10). If the UMAP Components 1 an"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T349","span":{"begin":108,"end":110},"obj":"Disease"},{"id":"T350","span":{"begin":115,"end":117},"obj":"Disease"}],"attributes":[{"id":"A349","pred":"mondo_id","subj":"T349","obj":"http://purl.obolibrary.org/obo/MONDO_0007739"},{"id":"A350","pred":"mondo_id","subj":"T350","obj":"http://purl.obolibrary.org/obo/MONDO_0009973"}],"text":"esponses. To investigate this immune signature, we identified 20 patients who had responses more similar to HD and RD for five activated/responding B and T cell populations (Fig. 6J, middle, and fig. S10). If the UMAP Components 1 an"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T801","span":{"begin":115,"end":117},"obj":"http://purl.obolibrary.org/obo/CLO_0008770"},{"id":"T802","span":{"begin":127,"end":136},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T803","span":{"begin":148,"end":149},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T804","span":{"begin":154,"end":160},"obj":"http://purl.obolibrary.org/obo/CL_0000084"}],"text":"esponses. To investigate this immune signature, we identified 20 patients who had responses more similar to HD and RD for five activated/responding B and T cell populations (Fig. 6J, middle, and fig. S10). If the UMAP Components 1 an"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T8435","span":{"begin":108,"end":110},"obj":"Chemical"},{"id":"T70189","span":{"begin":115,"end":117},"obj":"Chemical"}],"attributes":[{"id":"A73267","pred":"chebi_id","subj":"T8435","obj":"http://purl.obolibrary.org/obo/CHEBI_73925"},{"id":"A51912","pred":"chebi_id","subj":"T70189","obj":"http://purl.obolibrary.org/obo/CHEBI_73812"}],"text":"esponses. To investigate this immune signature, we identified 20 patients who had responses more similar to HD and RD for five activated/responding B and T cell populations (Fig. 6J, middle, and fig. S10). If the UMAP Components 1 an"}

{"project":"LitCovid-sentences","denotations":[{"id":"T295","span":{"begin":10,"end":205},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"esponses. To investigate this immune signature, we identified 20 patients who had responses more similar to HD and RD for five activated/responding B and T cell populations (Fig. 6J, middle, and fig. S10). If the UMAP Components 1 an"}